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To the Editor: 19 
There is an increasing move towards screening carehome residents for cognitive issues.  Many tools 20 
are available for cognitive assessment in older adults with little guidance on the optimal approach 21 
and consequent heterogeneity in approach.[1]  The Alzheimer’s Society have produced a “toolkit” 22 
that recommends particular assessment tools for differing healthcare settings.[2]  For carehomes, 23 
Hodkinson’s abbreviated mental test (AMT) [3] and/or General Practitioner assessment of cognition 24 
(GPCOG) are suggested as initial screens[4].  Where there is cognitive impairment the Montreal 25 
Cognitive Assessment (MoCA) [5] is suggested.  All three tests may often be used, with AMT/GPCOG 26 
suggesting a cognitive impairment that is then characterised with MoCA.  27 
There is a literature describing cognitive screening test properties such as accuracy and reliability.[6]  28 
Other important, but less well described, metrics are feasibility and acceptability.  Understanding 29 
these properties is crucial for implementing a tool into practice.  We sought to assess these 30 
properties for the cognitive assessments recommended for carehomes. 31 
  32 
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Methods 33 
We performed cross-sectional assessment in all NHS continuing care (NHS-CC) units in Glasgow, UK.  34 
NHS-CC units offer professional nursing level care and frequent medical review to residents with 35 
complex physical and mental health needs.   36 
Within each NHS-CC unit, the assessor approached senior staff to discuss suitability for cognitive 37 
testing.  A standardised question was used “Do you feel this resident is suitable for any form of 38 
cognitive testing?” and final decision on whether testing would proceed was made by NHS-CC staff.  39 
A-priori we decided that patients in last days of life or where treatment was purely palliative would 40 
not be tested.  Patients felt to be unsuitable for any form of testing (medically unstable, end of life 41 
care) were excluded, all other patients were approached for assessment.   42 
We recorded if patients refused cognitive testing; were unable to attempt any of the tests or were 43 
unavailable on two occasions.  Assessment was in a fixed order AMT, GPCOG and MoCA.  Testing 44 
was performed in one session and if patient became distressed or struggled to complete testing then 45 
assessment was discontinued.  We recorded test scores; time taken to complete tests and described 46 
numbers completing tests and resulting scores.  The project was assessed as audit of practice and 47 
had approval from the local Caldicott guardian.  48 
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Results 49 
We assessed patients across all six city NHS-CC units, n=222 patients, 107 (48%) had a formal 50 
dementia diagnosis.   51 
In total 73 (33%) completed at least one test, median age:82 years (IQR: 76-88); n=50 female (40%); 52 
25 (34%) had a formal dementia diagnosis.  All patients completed AMT, 23 (32%) completed all 53 
three tests.(Figure 1)  Median assessment time:6 minutes (IQR: 4-15;range:2-34); for patients 54 
completing all three tests median assessment time:11minutes (IQR:15-24).  At usual thresholds for 55 
“screen positive” n=3 (4%) screened as no cognitive impairment.(Figure 1) 56 
Limiting to the 25 with formal dementia diagnosis (where MoCA is recommended as primary test), 6 57 
(24%) participants were able to complete MoCA testing, 12 (48%) completed GPCOG and all 58 
completed AMT.  59 
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Discussion 60 
Our results highlight the challenges of even basic cognitive assessment in a carehome setting.  61 
Routine assessment of all care-home residents using recommended tools may not be feasible and 62 
even a short test battery is associated with substantial non-completion and administration time.   63 
The three recommended assessments have differing purposes and do not necessarily have to be 64 
administered in sequence.  The added test burden of performing all three assessments in a single 65 
session may have biased results particularly for MoCA which was always performed last.  Accepting 66 
this caveat, our data would suggest that AMT is a reasonable first step screening assessment.  The 67 
low completion rate and high prevalence of cognitive impairment at usual thresholds suggests that 68 
MoCA may not be suited to carehome settings.   69 
Our measures of test suitability, acceptance and completion suggest that issues with feasibility of a 70 
universal cognitive screening approach.  We did not operationalize suitability for assessment but 71 
rather left this to the discretion of the senior unit staff.  We feel this approach mirrors the real world 72 
setting.  Although NHS-CC is a UK specific resource, the casemix will be similar to higher level 73 
“nursing home” / longterm care facilities and we feel our findings have external validty.   74 
 75 
Conclusion  76 
Time required and limited completion rates suggest that cognitive screening should use the shortest 77 
validated tool.  With the very high prevalence of cognitive impairment in NHS-CC patients (at usual 78 
test thresholds) it could be argued whether “screening” for cognitive impairment per se is 79 
worthwhile.  Targeted assessment for common incident problems that may require intervention 80 
such as delirium may be a more useful approach to cognitive assessment in carehome settings. 81 
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Figure 1: Flow diagram illustrating test completion and proportions completing and screening test 
positive for cognitive impairment 
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